Amarantus Bioscience Holdings Inc
OTC:AMBS
Income Statement
Earnings Waterfall
Amarantus Bioscience Holdings Inc
Income Statement
Amarantus Bioscience Holdings Inc
| Oct-2008 | Jan-2009 | Apr-2009 | Jul-2009 | Oct-2009 | Jan-2010 | Apr-2010 | Jul-2010 | Oct-2010 | Jan-2011 | Apr-2011 | Jun-2011 | Sep-2011 | Dec-2011 | Mar-2012 | Jun-2012 | Sep-2012 | Dec-2012 | Mar-2013 | Jun-2013 | Sep-2013 | Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
3
|
3
|
2
|
2
|
2
|
1
|
0
|
0
|
0
|
2
|
3
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+459%
|
0
-78%
|
0
N/A
|
0
-80%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Gross Profit | ||||||||||||||||||||||||||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||||||||||||||||||||||||||||
| Operating Expenses |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(2)
|
(4)
|
(5)
|
(5)
|
(5)
|
(4)
|
(5)
|
(5)
|
(5)
|
(6)
|
(5)
|
(15)
|
(18)
|
(21)
|
(28)
|
(36)
|
(35)
|
(25)
|
(27)
|
|
| Selling, General & Administrative |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
(5)
|
(6)
|
(8)
|
(11)
|
(16)
|
(16)
|
(12)
|
(13)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(3)
|
(5)
|
(14)
|
(16)
|
(19)
|
(18)
|
(13)
|
(15)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(7)
|
(7)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(0)
N/A
|
(0)
-50%
|
(0)
+33%
|
(0)
+50%
|
(0)
-100%
|
(0)
N/A
|
(0)
-50%
|
(0)
-67%
|
(0)
-17%
|
(0)
-54%
|
(0)
+11%
|
(1)
-1 338%
|
(2)
-38%
|
(4)
-135%
|
(5)
-30%
|
(5)
+3%
|
(5)
-3%
|
(4)
+16%
|
(5)
-13%
|
(5)
-8%
|
(5)
-2%
|
(6)
-13%
|
(5)
+4%
|
(15)
-168%
|
(18)
-23%
|
(21)
-19%
|
(28)
-29%
|
(36)
-31%
|
(35)
+1%
|
(25)
+30%
|
(27)
-11%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(4)
|
(4)
|
(6)
|
(2)
|
(3)
|
(3)
|
(1)
|
(0)
|
(1)
|
(0)
|
(1)
|
2
|
3
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(7)
|
(7)
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(1)
|
(1)
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(4)
|
(4)
|
(5)
|
(4)
|
(0)
|
(0)
|
(2)
|
(1)
|
(1)
|
|
| Pre-Tax Income |
(0)
N/A
|
(0)
-50%
|
(0)
+33%
|
(0)
+50%
|
(0)
-100%
|
(0)
N/A
|
(0)
-50%
|
(0)
-67%
|
(0)
-17%
|
(0)
-54%
|
(0)
+11%
|
(1)
-1 388%
|
(2)
-55%
|
(4)
-141%
|
(6)
-27%
|
(6)
+2%
|
(5)
+2%
|
(5)
+5%
|
(8)
-65%
|
(9)
-2%
|
(11)
-29%
|
(15)
-36%
|
(19)
-26%
|
(22)
-15%
|
(23)
-6%
|
(27)
-17%
|
(28)
-4%
|
(37)
-29%
|
(38)
-3%
|
(25)
+33%
|
(27)
-6%
|
|
| Net Income | ||||||||||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(2)
|
(4)
|
(6)
|
(6)
|
(5)
|
(5)
|
(8)
|
(9)
|
(11)
|
(15)
|
(19)
|
(22)
|
(23)
|
(27)
|
(28)
|
(37)
|
(38)
|
(25)
|
(27)
|
|
| Net Income (Common) |
(0)
N/A
|
(0)
-50%
|
(0)
+33%
|
(0)
+50%
|
(0)
-100%
|
(0)
N/A
|
(0)
-50%
|
(0)
-67%
|
(0)
-17%
|
(0)
-54%
|
(0)
+11%
|
(1)
-1 388%
|
(2)
-55%
|
(4)
-141%
|
(6)
-27%
|
(6)
+2%
|
(5)
+2%
|
(5)
+5%
|
(8)
-65%
|
(9)
-2%
|
(11)
-29%
|
(15)
-36%
|
(19)
-27%
|
(22)
-15%
|
(23)
-6%
|
(28)
-20%
|
(30)
-7%
|
(42)
-41%
|
(46)
-8%
|
(37)
+19%
|
(50)
-34%
|
|
| EPS (Diluted) |
-0.01
N/A
|
-0.02
-100%
|
-0.01
+50%
|
0
N/A
|
-0.01
N/A
|
0
N/A
|
-0.01
N/A
|
-0.02
-100%
|
-0.03
-50%
|
-0.05
-67%
|
-0.05
N/A
|
-3.21
-6 320%
|
-4.08
-27%
|
-12.65
-210%
|
-9.59
+24%
|
-9.85
-3%
|
-7.21
+27%
|
-5.48
+24%
|
-3.44
+37%
|
-3.26
+5%
|
-3.49
-7%
|
-5.05
-45%
|
-4.57
+10%
|
-3.86
+16%
|
-4.57
-18%
|
-5.35
-17%
|
-3.77
+30%
|
-5.57
-48%
|
-5.7
-2%
|
-4.17
+27%
|
-1.47
+65%
|
|